Navigation Links
OncoGenex To Present At The RBC Capital Markets 2008 Healthcare Conference
Date:12/4/2008

BOTHELL, WA, and VANCOUVER, Dec. 4 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc (NASDAQ: OGXI) will participate on the 'Waging a Battle Against Cancer' panel at the RBC Capital Markets 2008 Healthcare Conference on Thursday, December 11 at 8:00 am ET at the Westin Times Square Hotel in New York. During the panel discussion, OncoGenex' President and Chief Executive Officer, Scott Cormack, will provide a brief overview of the company's oncology drug pipeline and its approach for addressing cancer treatment resistance.

A live webcast of the panel will be available on the Events section of the Investor Relations page of the company Web site at www.oncogenex.com. A replay of the webcast will be available for 30 days following the event.

About OncoGenex Pharmaceuticals

OncoGenex Pharmaceuticals is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address unmet needs in the treatment of cancer. OncoGenex has a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OGX-011, the lead candidate currently completing five Phase 2 clinical studies in prostate, lung and breast cancers, is designed to inhibit the production of a specific protein associated with treatment resistance; OGX-427 and SN2310 are in Phase 1 clinical development; and CSP-9222 and OGX-225 are currently in pre-clinical development. More information is available at www.oncogenex.com.


'/>"/>
SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer
2. Sonus Pharmaceuticals and OncoGenex Technologies to Merge
3. OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference
4. OncoGenex increases economic interest in lead cancer drug OGX-011
5. OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011
6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
7. FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals Lead Product Candidate OGX-011
8. OncoGenex Pharmaceuticals announces out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals
9. OncoGenex To Present At The BioContact Quebec 2008 Annual Conference
10. OncoGenex Achieves Key Regulatory Milestone for Lead Product Candidate, OGX-011
11. OncoGenex Pharmaceuticals to Release Third Quarter Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...y approved the Promega PowerPlex 16 HS System for ... DNA records for the National DNA Index System. ,...- The FBI recently approved the Promega PowerPlex...ipating in, or generating DNA records for, the Nat...ains more than seven million profiles and has assi...
(Date:11/24/2009)...ewswire-FirstCall/ -- Shire plc (LSE: SHP,NASDAQ:...company, today,announced that it has submitted a M...ase alfa, the company,s enzyme replacement therapy...r disease. This is the third marketing,application...ith previous,submissions in the United States and ...
(Date:11/24/2009).../--HealthRoboticstodayannounced,thatithasformedane...s.ThisrecentlyformedToronto-basedcompanywilloperat...et,install,andsupport,HealthRobotics,i.v.Roomofthe...tofferingsi.v.STATION(TM),i.v.SOFT(TM),andOMM(TM)....onan"asneeded,basis"toitsstrategicpartnershipswith...
(Date:11/24/2009)...ire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (N...e 21st Annual Piper Jaffray Health Care Conference...at the New York Palace Hotel. ,, CTI will pre...Time in Holmes 1 (4th Floor). A live audio webcast...elltherapeutics.com , and it will also be availabl...
Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
...tions Solution Demonstrated at HIMSS 2009 , , BER...ng Corp. (Nasdaq: ADAT ), a worldwide provider o...management services, today announced that it has i...ith Nortel,s Patient Discharge Solution (PDS) to i...ls are looking to automate and accelerate the pati...
...UROPE, CANSO, EUROCONTROL and IATA launched a join...y aircraft in Europe by over half a million tonnes...rland (PRWEB) April 6, 2009 -- ACI EUROPE, CANSO, ...designed to reduce the CO2 emitted by aircraft in ..., ,The plan, launched at the 4th Aviation and Env...
...ER TOLEDO invites you to view our latest particle ...ciation of Pharmaceutical Scientists (AAPS) Worksh...rocess Control in QbD based Drug Development and M... MD (PRWEB) April 5, 2009 -- Particles play a crit...nd control of particles ensures Quality by Design ...
Other Biology Technology:Authentidate Teams with Nortel to Enhance Hospital Patient Discharge and Placement Processes 2Authentidate Teams with Nortel to Enhance Hospital Patient Discharge and Placement Processes 3Authentidate Teams with Nortel to Enhance Hospital Patient Discharge and Placement Processes 4Aviation partners to cut 500,000 tonnes of CO2 a year 2METTLER TOLEDO and AAPS: Utilization of Process Modeling and Advanced Process Control in QbD based Drug Development and Manufacturing 2
(Date:11/24/2009)...s been prescribed by traditional healers in Brazil...tomach pain to fever and flu. , Now for the first...en able to scientifically prove the pain relieving...s Brazilian mint. , Testing this ancient South Am...aciela Rocha was able to show that when prepared a...
(Date:11/24/2009)... a protein that may help gut bacteria bind to the ...by probiotic producers to identify strains that ar...iotics need to interact with cells lining the gut ... surfaces in the gut they are more likely to stick... Dr Nathalie Juge from the Institute of Food Resea...
(Date:11/24/2009)...llege of Medical Toxicology (ACMT) have signed an ... Journal of Medical Toxicology (JMT), the offici...It was previously published by the University of P...xicology , an international, peer-reviewed journal...ce of medical toxicology. The quarterly journal f...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2A sticky solution for identifying effective probiotics 2Springer and the American College of Medical Toxicology to work together 2Carvedilol shown to have unique characteristics among beta blockers 10832 1Carvedilol shown to have unique characteristics among beta blockers 10832 2Using Cell Phones Internet to Battle Eating Disorders 61807 1Using Cell Phones Internet to Battle Eating Disorders 61807 2VidaOne 26apos 3Bs New iPhone Fitness Application Featured in App Store What 26apos 3Bs Hot List 61804 1VidaOne 26apos 3Bs New iPhone Fitness Application Featured in App Store What 26apos 3Bs Hot List 61804 2VidaOne 26apos 3Bs New iPhone Fitness Application Featured in App Store What 26apos 3Bs Hot List 61804 3
...ntological Society of America is inviting all jou...ing the country,s largest interdisciplinary confe...2008. Media representatives can register free of ...d National Resort & Convention Center in Nationa...nt to Washington, DC, on the shores of the Potomac...
...have found bacteria in the root of a tropical gras...rfumery industries. These bacteria seem to promote...hange the molecular structure of the oil, giving i...nsecticidal, antimicrobial and antioxidant. , Stu...gh interdisciplinary research, the microbiologists...
...rkers responding to devastating flooding in Hondur...lite images of affected areas provided rapidly fol...Space and Major Disasters. , Tens of thousands of... claimed by floods and landslides brought on by a ...country on 16 October. , On 27 October, the UN Ins...
Other Biology News:Resilience in an aging society: GSA showcases cutting-edge meeting topics 2Resilience in an aging society: GSA showcases cutting-edge meeting topics 3Resilience in an aging society: GSA showcases cutting-edge meeting topics 4Bacteria manage perfume oil production from grass 2Satellites helping aid workers in Honduras 2
PI/RNase Staining Buffer Solution from BD Biosciences Pharmingen
Mouse Anti-Selenoprotein P Monoclonal Antibody, Unconjugated, Clone 35 from BD Biosciences Pharmingen
Rat Anti-Mouse Reticular Fibroblast (pan) Monoclonal Antibody, Unconjugated, Clone ER-TR7 from CEDARLANE Laboratories Limited
Rabbit Anti-HPRT Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products: